73217-31-9 Usage
General Description
3-(Chloromethyl)-5-(4-methoxyphenyl)-1,2,4-oxadiazole is a chemical compound with the molecular formula C10H9ClN2O2. It is a derivative of 1,2,4-oxadiazole and contains a chloromethyl group and a 4-methoxyphenyl group. 3-(CHLOROMETHYL)-5-(4-METHOXYPHENYL)-1,2,4-OXADIAZOLE has potential applications in the field of medicinal chemistry and pharmaceutical research, as it exhibits biological activities that are being studied for potential therapeutic uses. Additionally, it may also be used in the synthesis of other organic compounds and as a building block for the creation of new materials with specific properties. The chemical and physical properties of 3-(chloromethyl)-5-(4-methoxyphenyl)-1,2,4-oxadiazole make it a versatile and potentially valuable compound for various scientific and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 73217-31-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,2,1 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 73217-31:
(7*7)+(6*3)+(5*2)+(4*1)+(3*7)+(2*3)+(1*1)=109
109 % 10 = 9
So 73217-31-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H9ClN2O2/c1-14-8-4-2-7(3-5-8)10-12-9(6-11)13-15-10/h2-5H,6H2,1H3
73217-31-9Relevant articles and documents
ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF
-
Page/Page column 62; 64, (2012/01/13)
The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, processes for their preparation, compositions comprising them and therapeutic uses thereof.
The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
Zablocki, Jeff,Kalla, Rao,Perry, Thao,Palle, Venkata,Varkhedkar, Vaibhav,Xiao, Dengming,Piscopio, Anthony,Maa, Tenning,Gimbel, Art,Hao, Jia,Chu, Nancy,Leung, Kwan,Zeng, Dewan
, p. 609 - 612 (2007/10/03)
Adenosine has been suggested to play a role in asthma, possibly via activation of A2B adenosine receptors on mast cells and other pulmonary cells. We describe our initial efforts to discover a xanthine based selective A2B AdoR antagonist that resulted in the discovery of CVT-5440, a high affinity A2B AdoR antagonist with good selectivity (A2B AdoR Ki = 50 nM, selectivity A1 > 200: A2A > 200: A3 > 167).